INKE SA
INKE SA (Spain) holds 24 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 24 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “INKE SA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/inke-sa
Overview
INKE SA is an active pharmaceutical ingredient (API) supplier with 24 active FDA Type II Drug Master Files, covering ACLIDINIUM BROMIDE; APREPITANT; ARFORMOTEROL TARTRATE (FORM A); ARFORMOTEROL TARTRATE (FORM D); CLEVIDIPINE BUTYRATE; FLUCONAZOLE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which INKE SA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
INKE SA holds 24 active (26 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- INDACATEROL MALEATE (MICRONIZED AND NON-MICRONIZED)Active2024-06-25
- OLODATEROL HYDROCHLORIDEActive2023-07-21
- UMECLIDINIUM BROMIDEActive2023-06-16
- ACLIDINIUM BROMIDEActive2023-03-16
- VILANTEROL TRIFENATATEActive2023-03-16
- REVEFENACIN TRIHYDRATEActive2022-07-27
- TETRABENAZINEActive2022-06-21
- CLEVIDIPINE BUTYRATEActive2022-06-14
- ARFORMOTEROL TARTRATE (FORM A)Active2022-05-16
- APREPITANTActive2022-04-26
- TIOTROPIUM BROMIDE MONOHYDRATE (MICRONIZED AND NON-MICRONIZED)Active2020-03-17
- ARFORMOTEROL TARTRATE (FORM D)Active2018-07-25
- GLYCOPYRROLATEActive2017-07-22
- OLANZAPINEActive2013-01-24
- RIZATRIPTAN BENZOATEActive2011-12-22
- ZOLMITRIPTANActive2011-02-14
- SALMETEROL XINAFOATEActive2010-06-23
- GRANISETRON BASEActive2008-06-24
- GRANISETRON HYDROCHLORIDEActive2004-04-05
- FORMOTEROL FUMARATEActive2003-06-03
- ONDANSETRON HYDROCHLORIDEActive2002-12-13
- ONDANSETRON BASEActive2002-09-30
- RISPERIDONEActive2001-10-23
- FLUCONAZOLEActive1999-12-15
- QUETIAPINE HEMIFUMARATEInactive2006-06-16
- LORATADINEInactive1998-10-20
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to INKE SA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to INKE SA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this INKE SA?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.